These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26963497)

  • 21. A validated enantioselective LC-MS/MS assay for quantification of a major chiral metabolite of an achiral 11-β-hydroxysteroid-dehydrogenase 1 inhibitor in human plasma: Application to a clinical pharmacokinetic study.
    Furlong MT; Ji QC; Iacono L; Dang O; Noren M; Bruce J; Aubry AF; Arnold ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():167-172. PubMed ID: 27100678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A validated enantioselective LC-MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: application to a clinical pharmacokinetic study.
    Furlong MT; He B; Mylott W; Zhao S; Mariannino T; Shen J; Stouffer B
    J Pharm Biomed Anal; 2012 Nov; 70():574-9. PubMed ID: 22709607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chiral LC-MS/MS method for the simultaneous determination of (R,S)-ketamine, (R,S)-norketamine, and (2R,6R;2S,6S)-hydroxynorketamine in mouse plasma and brain.
    Toki H; Yamaguchi JI; Mizuno-Yasuhira A; Endo H
    J Pharm Biomed Anal; 2023 Feb; 224():115168. PubMed ID: 36473323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
    Furlong MT; Agrawal S; Hawthorne D; Lago M; Unger S; Krueger L; Stouffer B
    J Pharm Biomed Anal; 2012 Jan; 58():130-5. PubMed ID: 21982905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput assay for quantification of the plasma concentrations of thiopental using automated solid phase extraction (SPE) directly coupled to LC-MS/MS instrumentation.
    Moosavi SM; Shekar K; Fraser J; Smith MT; Ghassabian S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Dec; 1038():80-87. PubMed ID: 27802918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formation of threohydrobupropion from bupropion is dependent on 11β-hydroxysteroid dehydrogenase 1.
    Meyer A; Vuorinen A; Zielinska AE; Strajhar P; Lavery GG; Schuster D; Odermatt A
    Drug Metab Dispos; 2013 Sep; 41(9):1671-8. PubMed ID: 23804523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bupropion plasma levels and CYP2D6 phenotype.
    Pollock BG; Sweet RA; Kirshner M; Reynolds CF
    Ther Drug Monit; 1996 Oct; 18(5):581-5. PubMed ID: 8885123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative chiral and achiral determination of ketamine and its metabolites by LC-MS/MS in human serum, urine and fecal samples.
    Hasan M; Hofstetter R; Fassauer GM; Link A; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2017 May; 139():87-97. PubMed ID: 28279931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-throughput quantitation of nefazodone and its metabolites in human plasma by high flow direct-injection LC-MS/MS.
    Mao Y; Huang MQ; Xia YQ; Jemal M
    J Pharm Biomed Anal; 2007 Apr; 43(5):1808-19. PubMed ID: 17236738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a bioanalytical method for the simultaneous determination of heroin, its main metabolites, naloxone and naltrexone by LC-MS/MS in human plasma samples: Application to a clinical trial of oral administration of a heroin/naloxone formulation.
    Moreno-Vicente R; Fernández-Nieva Z; Navarro A; Gascón-Crespí I; Farré-Albaladejo M; Igartua M; Hernández RM; Pedraz JL
    J Pharm Biomed Anal; 2015 Oct; 114():105-12. PubMed ID: 26037158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LC-MS/MS method for the determination of clodronate in human plasma.
    Hasan M; Schumacher G; Seekamp A; Taedken T; Siegmund W; Oswald S
    J Pharm Biomed Anal; 2014 Nov; 100():341-347. PubMed ID: 25194348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid quantification of amlodipine enantiomers in human plasma by LC-MS/MS: application to a clinical pharmacokinetic study.
    Hotha KK; Roychowdhury S; Mullangi R; Ravindranath LK
    Biomed Chromatogr; 2013 Sep; 27(9):1192-9. PubMed ID: 23640924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene variants in CYP2C19 are associated with altered in vivo bupropion pharmacokinetics but not bupropion-assisted smoking cessation outcomes.
    Zhu AZ; Zhou Q; Cox LS; Ahluwalia JS; Benowitz NL; Tyndale RF
    Drug Metab Dispos; 2014 Nov; 42(11):1971-7. PubMed ID: 25187485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stereoselective bupropion hydroxylation as an in vivo phenotypic probe for cytochrome P4502B6 (CYP2B6) activity.
    Kharasch ED; Mitchell D; Coles R
    J Clin Pharmacol; 2008 Apr; 48(4):464-74. PubMed ID: 18287571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS/MS with electrospray ionization: assay development, validation and application to a clinical study.
    Trivedi RK; Kallem RR; Mullangi R; Srinivas NR
    J Pharm Biomed Anal; 2005 Sep; 39(3-4):661-9. PubMed ID: 15970417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transport of Bupropion and its Metabolites by the Model CHO and HEK293 Cell Lines.
    Han LW; Gao C; Zhang Y; Wang J; Mao Q
    Drug Metab Lett; 2019; 13(1):25-36. PubMed ID: 30488806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute antidepressant response and plasma levels of bupropion and metabolites in a pediatric-aged sample: an exploratory study.
    Daviss WB; Perel JM; Brent DA; Axelson DA; Rudolph GR; Gilchrist R; Nuss S; Birmaher B
    Ther Drug Monit; 2006 Apr; 28(2):190-8. PubMed ID: 16628130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose pharmacokinetics of bupropion in adolescents: effects of smoking status and gender.
    Stewart JJ; Berkel HJ; Parish RC; Simar MR; Syed A; Bocchini JA; Wilson JT; Manno JE
    J Clin Pharmacol; 2001 Jul; 41(7):770-8. PubMed ID: 11452710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
    Jefferson JW; Pradko JF; Muir KT
    Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enantioselective determination of ornidazole in human plasma by liquid chromatography-tandem mass spectrometry on a Chiral-AGP column.
    Du J; Ma Z; Zhang Y; Wang T; Chen X; Zhong D
    J Pharm Biomed Anal; 2013 Dec; 86():182-8. PubMed ID: 24004635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.